You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PET-MF

Showing 26 - 50 of 4,962
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Graves Disease Trial in Göteborg (MF course, Usual health care)

Recruiting
  • Graves Disease
  • MF course
  • Usual health care
  • Göteborg, Sweden
    Agneta Lindo
Nov 17, 2023

Aspergillosis and Haematological Malignancy Trial in Paris (imaging 18F-FDG-PET/CT, Blood collection)

Active, not recruiting
  • Aspergillosis and Haematological Malignancy
  • imaging 18F-FDG-PET/CT
  • Blood collection
  • Paris, France
    Department of Infectious Diseases and Tropical Medicine, Necker
Dec 6, 2021

Myelofibrosis, Primary Myelofibrosis, Post-PV MF Trial in Canton (TL-895, Ruxolitinib)

Recruiting
  • Myelofibrosis
  • +3 more
  • Birmingham, Alabama
  • +13 more
Jan 10, 2023

Alzheimer's Disease, Dementia, Mild Cognitive Impairment Trial in Philadelphia (PET Scan)

Completed
  • Alzheimer's Disease
  • +2 more
  • PET Scan
  • Philadelphia, Pennsylvania
  • +1 more
Jul 19, 2021

Presbyopia Trial in Johns Creek (Lehfilcon A multlifocal contact lenses, Lotrafilcon B multifocal contact lenses, Hydrogen

Recruiting
  • Presbyopia
  • Lehfilcon A multlifocal contact lenses
  • +2 more
  • Johns Creek, Georgia
    Johns Creek Research Clinic
Mar 13, 2023

Head and Neck Squamous Cell Carcinoma, Lymphoma, Glioma Trial in London (Glucose infusion, Magnetic Resonance Imaging (MRI), FDG

Completed
  • Head and Neck Squamous Cell Carcinoma
  • +2 more
  • Glucose infusion
  • +2 more
  • London, United Kingdom
    University College London Hospital
Sep 28, 2021

Presbyopia Trial in Johns Creek (Lehfilcon A multifocal contact lenses, Lotrafilcon B multifocal contact lenses, Hydrogen

Recruiting
  • Presbyopia
  • Lehfilcon A multifocal contact lenses
  • +2 more
  • Johns Creek, Georgia
    Alcon Study Site 07898
Feb 3, 2023

Primary Myelofibrosis Trial (Pacritinib)

Withdrawn
  • Primary Myelofibrosis
  • Pacritinib
  • (no location specified)
May 3, 2021

Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), Post-Essential Thrombocythemia Myelofibrosis

Terminated
  • Primary Myelofibrosis (PMF)
  • +2 more
  • Larkspur, California
  • +2 more
Nov 14, 2022

T-Cell Tumor, Lymphoproliferative Disorders Trial in Ann Arbor (Pacritinib)

Not yet recruiting
  • T-Cell Neoplasm
  • Lymphoproliferative Disorders
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Oct 6, 2022

History of Myocardial Infarction Trial in Boston (18F-FDG PET/CT)

Recruiting
  • History of Myocardial Infarction
  • 18F-FDG PET/CT
  • Boston, Massachusetts
    Massachusetts General Hospital, Havard Medical School
Nov 30, 2021

Ruxolitinib in Patients With Myelofibrosis

Completed
  • Myelofibrosis
  • (no location specified)
Jun 5, 2022

Sezary Syndrome, Mycosis Fungoides Trial in Stanford (Mogamulizumab, LD TSEBT)

Recruiting
  • Sezary Syndrome
  • Mycosis Fungoides
  • Stanford, California
    Stanford Cancer Center
Oct 19, 2022

Myelofibrosis Trial in Belgium, Netherlands (Pacritinib)

Active, not recruiting
  • Myelofibrosis
  • Antwerpen, Belgium
  • +11 more
Aug 19, 2022

Myelofibrosis, Primary Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis Trial in Worldwide (parsaclisib, ruxolitinib,

Recruiting
  • Myelofibrosis
  • +3 more
  • Anchorage, Alaska
  • +172 more
Dec 1, 2022

Mycosis Fungoides Trial (Imiquimod, Radiation Therapy)

Not yet recruiting
  • Mycosis Fungoides
  • (no location specified)
Apr 29, 2023

Mycosis Fungoides Trial in Edmonton (Cemiplimab)

Not yet recruiting
  • Mycosis Fungoides
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Sep 12, 2022

Adult T-Cell Lymphoma/Leukemia, Sezary Syndrome, Mycosis Fungoides Trial run by the NCI (Recombinant human Interleukin-15

Completed
Has Results
  • Adult T-Cell Lymphoma/Leukemia
  • +2 more
  • Recombinant human Interleukin-15 (rhIL-15)
  • Mogamulizumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 9, 2022

Diagnostic Classifier for Cutaneous T-cell Lymphomas

Recruiting
  • CTCL/ Mycosis Fungoides
  • Skin suction blistering and skin biopsies
  • Vienna, Austria
    Medical University of Vienna
Apr 4, 2022

Cystic Fibrosis Trial in Worldwide (ELX/TEZ/IVA, IVA, Placebo (matched to ELX/TEZ/IVA))

Completed
Has Results
  • Cystic Fibrosis
  • Nedlands, Australia
  • +33 more
Jul 1, 2022

Interleukin (IL) -35 in Mycosis Fungoides:Case Control Study

Recruiting
  • Mycosis Fungoides
  • Skin biopsy
  • Giza, Egypt
    Cairo University
May 3, 2023

Lymphoma, Non-Hodgkin, Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma Trial in Vancouver (Cyclophosphamide,

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma
  • Vancouver, British Columbia, Canada
    BC Cancer Agency
Jul 20, 2021

Myelofibrosis, Moderate Thrombocytopenia Trial (Selinexor)

Not yet recruiting
  • Myelofibrosis
  • Moderate Thrombocytopenia
  • (no location specified)
Jul 31, 2023

Focal Segmental Glomerulosclerosis Trial (Metformin + Standard of Care, Placebo + Standard of Care)

Not yet recruiting
  • Focal Segmental Glomerulosclerosis
  • Metformin + Standard of Care
  • Placebo + Standard of Care
  • (no location specified)
Oct 13, 2023

Mandibular Flexure Trial in Puebla (Mandibular flexure evaluation)

Completed
  • Mandibular Flexure
  • Mandibular flexure evaluation
  • Puebla, Mexico
    Benemérita Universidad Autónoma de Puebla
Feb 6, 2023